Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1144414]Researchers: A/Pr Suzanne Miller (Principal investigator) , A/Pr Michael Fahey , Prof Jonathan Hirst , Prof Laura Bennet
Brief description Around 10% of neonates in Australia are diagnosed with seizures each year. Seizures worsen neurodevelopmental outcome following hypoxic brain injury. Despite evidence of the limited effectiveness and potential neurotoxicity of current anti-seizure medication, treatment has not changed for many decades. The objective of this study is to optimise treatment of neonatal seizures with a compound that is effective and does not cause harm, or indeed provides neuroprotection for the compromised brain.
Funding Amount $AUD 895,573.93
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1144414
- PURL : https://purl.org/au-research/grants/nhmrc/1144414